Regent Pacific Group Limited (HKG:0575)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.900
0.00 (0.00%)
At close: Mar 10, 2026
100.00%
Market Cap 262.63M
Revenue (ttm) 6.54M
Net Income (ttm) -32.00M
Shares Out 291.82M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 44,640
Open n/a
Previous Close 0.900
Day's Range n/a
52-Week Range 0.395 - 1.240
Beta 1.34
RSI 37.65
Earnings Date Mar 27, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog... [Read more]

Sector Healthcare
Founded 1991
Employees 17
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0575
Full Company Profile

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.